Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein | |
Yan, Bo ; Liu, Lei ; Huang, Shaoqiang ; Ren, Yan ; Wang, Huayi ; Yao, Zhenglin ; Li, Lin ; Chen, She ; Wang, Xiaodong ; Zhang, Zhiyuan | |
刊名 | CHEMICAL COMMUNICATIONS |
2017 | |
关键词 | CELL-DEATH MLKL NECROSIS RIP3 INFLAMMATION ACTIVATION |
DOI | 10.1039/c7cc00667e |
英文摘要 | We report the development of novel Mixed Lineage Kinase Domain-Like protein (MLKL) inhibitors with single nanomolar potency (compound 15 is also named as TC13172). Using the converting biochemistry to chemistry activity-based protein profiling (BTC-ABPP) method, we were able to determine that the inhibitors covalently bind to Cysteine86 (Cys-86) of MLKL. This is the first example of the use of LC-MS/MS to identify the binding site of an MLKL inhibitor. The novel MLKL inhibitors provide powerful tools to study the biological function of MLKL and demonstrate that MLKL should be viewed as a druggable target.; National Major Scientific and Technological Special Project for "Significant New Drugs Development'' during the Twelfth Five-year Plan from the Chinese Ministry of Science and Technology [2013ZX0950910]; SCI(E); ARTICLE; 26; 3637-3640; 53 |
语种 | 英语 |
内容类型 | 期刊论文 |
源URL | [http://ir.pku.edu.cn/handle/20.500.11897/474089] |
专题 | 生命科学学院 |
推荐引用方式 GB/T 7714 | Yan, Bo,Liu, Lei,Huang, Shaoqiang,et al. Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein[J]. CHEMICAL COMMUNICATIONS,2017. |
APA | Yan, Bo.,Liu, Lei.,Huang, Shaoqiang.,Ren, Yan.,Wang, Huayi.,...&Zhang, Zhiyuan.(2017).Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein.CHEMICAL COMMUNICATIONS. |
MLA | Yan, Bo,et al."Discovery of a new class of highly potent necroptosis inhibitors targeting the mixed lineage kinase domain-like protein".CHEMICAL COMMUNICATIONS (2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论